On June 10, 2026, Genprex, Inc. received a notice from Nasdaq indicating it will be delisted due to its stock closing below $1.00 for 30 consecutive business days. The company plans to request a hearing to avoid delisting and may consider a reverse stock split to comply with Nasdaq's requirements.